Barclays PLC Pro Phase Labs, Inc. Transaction History

Barclays PLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 03, 2023	BUY	$7.15 - $9.78 $1,058 - $1,447	148 New	148 $1,000
Q2 2021 Aug 13, 2021	SELL	$4.61 - $6.83 $2,291 - $3,394	-497 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$6.19 - $16.0 $3,076 - $7,952	497 New	497 $4,000
Q3 2020 Nov 12, 2020	SELL	$1.4 - $3.87 $26 - $73	-19 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$1.2 - $1.99 $22 - $37	19 New	19 $0

Q2 2019 Aug 14, 2019	SELL	$2.1 - $3.07 $134 - $196	-64 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$2.7 - $3.65 $172 - $233	64 New	64 $0
Q2 2018 Aug 14, 2018	SELL	$2.84 - $5.41 $14 - $27	-5 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$2.24 - $3.21 $11 - $16	5 New	5 $0

1.66M

2.4K

Ticker PRPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 16,024,400
Market Cap $67M
Description
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.